MAPS Remains Hopeful, Awaits FDA Decision on MDMA-Assisted Therapy for PTSD
Dear Friends and Allies, On June 4, 2024, the U.S. Food and Drug Administration (FDA) convened a meeting of the Psychopharmacologic Drugs Advisory Committee to evaluate Lykos Therapeutics’ (Lykos) New …